k-ras mutation may be an early event in mucinous ovarian tumorigenesis

International Journal of Gynecological Pathology

Volumn 20, Issue 3, 2001, Pages 244-251

  Garrett, Audrey P ^a   Lee, Kenneth R ^a   Colitti, Cris R ^a   Muto, Michael G ^a   Berkowitz, Ross S ^a   Mok, Samuel C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Borderline; k ras; Mucinous; Ovarian; Tumorigenesis

Indexed keywords

ADULT; AGED; BENIGN TUMOR; CARCINOGENESIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; LASER MICROSCOPY; MALIGNANT TRANSFORMATION; MUCINOUS CARCINOMA; ONCOGENE K RAS; OVARY CARCINOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TISSUE SLICE; UNITED STATES;

EID: 0034982999     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200107000-00007     Document Type: Conference Paper

References (25)

1. Epithelial ovarian cancer
2. Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer
3. Borderline ovarian tumors
4. Long-term follow-up of serous ovarian tumors of low malignant potential
5. Current concepts in epithelial ovarian tumors: Does benign to malignant transformation occur?
6. Molecular sleuthing: Tracking ovarian cancer progression
7. Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas
8. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas
9. Comparison of mutations of Ki-ras and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors
10. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy
11. K-ras mutations in mucinous ovarian tumors: A clinicopathologic and molecular study of 95 cases
12. Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors
13. Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma
14. Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology
15. Ras oncogenes in human cancer: A review
16. Genetic events in sporadic colorectal adenomas: k-ras and p53 heterozygous mutations are not sufficient for malignant progression
17. Detection of Ki-ras mutation in non-neoplastic mucosa of Japanese patients with colorectal cancers
18. A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma
19. Frequent and characteristic K-ras activation in aberrant crypt foci of colon: Is there a preference among K-ras mutants for malignant progression?
20. Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer
21. Ovarian dysplasia: A study of twins
22. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies
23. Contralateral ovary in unilateral ovarian carcinoma: A search for preneoplastic lesions
24. Ovarian intraepithelial neoplasia demonstrated in patients with Stage 1 ovarian carcinoma
25. Early de novo ovarian carcinoma: A study of 14 cases